772. Access Denied: Impact of Insurance Denials for High-Cost Outpatient Parenteral Antimicrobial Therapy

BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) allows patients to receive prolonged antimicrobial therapy while reducing the length of hospitalization and healthcare costs. In the United States, most public and private insurance companies require prior authorization (PA) for OPAT. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchini, Monica L, Kenney, Rachel, Lentz, Robyn, Zervos, Marcus, Malhotra, Manu, Davis, Susan L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811214/
http://dx.doi.org/10.1093/ofid/ofz360.840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811214/
http://dx.doi.org/10.1093/ofid/ofz360.840

Ejemplares similares